Does Blue Cross Blue Shield Washington Cover Mounjaro? Washington BCBS Coverage Guide 2026
Washington-based patients wondering whether their Blue Cross Blue Shield plan covers Mounjaro, coverage varies based on several key factors. Premera Blue Cross handles coverage for a significant portion of Washington residents, and the formulary position on Mounjaro (generic: tirzepatide) is distinct from national BCBS guidelines.
Where Mounjaro Sits on Premera Blue Cross’s Drug List
Premera Blue Cross operates a drug list that doesn’t always match national BCBS formularies. Currently, Mounjaro is usually listed at Tier 3 (non-preferred specialty brand) across the majority of Premera Blue Cross commercial plans.
This means:
- Prior authorization is needed across most benefit designs
- Step therapy may apply — meaning you must try formulary-preferred drugs first
- Patient responsibility generally fall between $50–$150/month depending on benefit structure
- Certain Washington employer-sponsored BCBS plans may cover Mounjaro at a lower tier
At retail price, Mounjaro costs $1,000–$1,200 per month at Washington pharmacies.
Mounjaro Coverage for Different Indications in Washington
Premera Blue Cross’s coverage policies for Mounjaro are shaped by the diagnosis.
For type 2 diabetes (FDA-approved indication):
- Coverage is more straightforward
- Nearly all Washington BCBS plans authorize Mounjaro when medical necessity is demonstrated
- Required documentation usually involves failed prior therapy documentation
For weight loss (obesity treatment):
- Coverage is more restrictive
- You must demonstrate BMI ≥30 (or ≥27 plus at least one weight-related comorbidity)
- Several Washington plans deny weight loss drugs from formulary
How to Get Mounjaro Approved by Premera Blue Cross
Getting approval for Mounjaro with Premera Blue Cross involves specific steps.
- Verify your plan’s formulary — Call the number on your ID card to check Mounjaro’s formulary position on your specific plan
- Work with your prescriber submit prior authorization — Include complete clinical documentation
- Document failed prior therapies — Formulary compliance often requires proof of inadequate response to multiple first-line treatments first
- Challenge a denial — Premera Blue Cross offers two levels of internal appeal plus external review through
A 2024 KFF survey found that roughly 30% of GLP-1 prior authorization requests face first-round denial but over 60% are overturned on appeal.
What to Do After a Denial
Should Premera Blue Cross rejects Mounjaro coverage, explore the following options:
- Manufacturer savings programs — Eli Lilly has copay assistance that bring costs down to significantly less for eligible commercially insured patients
- Compounding pharmacy options — An option in Washington at lower prices, though not a formulary option
- Switch to a covered option — Premera Blue Cross could offer better coverage for an alternative in the same class
- Washington patient assistance programs — Check whether Washington has supplemental prescription assistance for specialty drugs
Summary for Washington BCBS Members
Premera Blue Cross can cover Mounjaro — getting approved is plan-specific and often requires your plan design and medical history. Start by reviewing your benefits and having your prescriber to build the strongest possible case.